ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,624.41
      1.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TCR2 Therapeutics Inc (TCRR)

      7. TCR2 Therapeutics Inc (TCRR) News

      TCRR

      TCR2 Therapeutics (TCRR)

      TCR2 Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRR
      DateTimeSourceHeadlineSymbolCompany
      03/18/20224:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/08/20224:30PMGlobeNewswire Inc.TCR² Therapeutics to Highlight Off-the-Shelf TRuC-T Cell at the American Association of Cancer Research Annual Meeting 2022NASDAQ:TCRRTCR2 Therapeutics Inc
      03/04/20224:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      02/14/20225:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRRTCR2 Therapeutics Inc
      02/09/20226:45AMGlobeNewswire Inc.TCR² Therapeutics to Present at the SVB Leerink Global Healthcare ConferenceNASDAQ:TCRRTCR2 Therapeutics Inc
      02/03/20224:45PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRRTCR2 Therapeutics Inc
      01/12/20226:58AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      01/12/20226:53AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRRTCR2 Therapeutics Inc
      01/12/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Announces Experienced Biotech Executive Rosemary Harrison as Chief Business and Strategy OfficerNASDAQ:TCRRTCR2 Therapeutics Inc
      01/10/20228:36AMTipRanksTCR2 Therapeutics (TCRR) Receives a Buy from Mizuho SecuritiesNASDAQ:TCRRTCR2 Therapeutics Inc
      01/10/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Announces 2022 Strategic Priorities and Anticipated MilestonesNASDAQ:TCRRTCR2 Therapeutics Inc
      01/07/20225:00PMGlobeNewswire Inc.TCR² Therapeutics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:TCRRTCR2 Therapeutics Inc
      01/05/20226:45AMGlobeNewswire Inc.TCR² Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceNASDAQ:TCRRTCR2 Therapeutics Inc
      01/04/202211:15AMTipRanksTCR2 Therapeutics (TCRR) Receives a Buy from Mizuho SecuritiesNASDAQ:TCRRTCR2 Therapeutics Inc
      01/04/20227:00AMGlobeNewswire Inc.TCR² Therapeutics and Arbor Biotechnologies Establish Collaboration to Advance Allogeneic TRuC-T Cell TherapiesNASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/10/20214:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/22/20211:45PMTipRanksMizuho Securities Sticks to Its Buy Rating for TCR2 Therapeutics (TCRR)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/22/20217:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/10/20217:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/10/20217:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/10/20216:45AMGlobeNewswire Inc.TCR² Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
      11/01/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      11/01/20214:05PMGlobeNewswire Inc.TCR² Therapeutics Announces Expansion of U.S. Manufacturing CapacityNASDAQ:TCRRTCR2 Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRR